Prostate Cancer - Results from #1380

Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer. February 8, 2024

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer. February 8, 2024

Association of extended core sampling with delayed intervention and pathologic outcomes for active surveillance patients: A population-based analysis. February 8, 2024

Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer. February 8, 2024

Deep learning-based automated pipeline for blood vessel detection and distribution analysis in multiplexed prostate cancer images. February 8, 2024

Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management. February 7, 2024

Shared medical decision in prostate cancer screening in primary care: a systematic literature review of current evidence. February 7, 2024

Retzius-sparing vs. posterior urethral suspension: similar early-phase post-robotic radical prostatectomy continence outcomes. February 7, 2024

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer. February 7, 2024

The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men. February 7, 2024

First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. February 6, 2024

A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11. February 6, 2024

A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells. February 6, 2024

Increased chromatin accessibility drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer. February 6, 2024

Key learning on the promise and limitations of MRI in prostate cancer screening. February 6, 2024

External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. February 6, 2024

Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre Trial. February 6, 2024

Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer. February 6, 2024

The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer. February 6, 2024

Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation Therapy for Prostate Cancer. February 5, 2024

Page 70 of 1435